Dr. Filipa Lynce, MD

  • Boston, MA
  • Pharmacy
NPI1144451261PAC ID5294052742
Medicare patients, 2024
76
Part D claims, 2024
39
MIPS score, 2024
84
Hospital affiliations
3
Industry payments
$11,482
Practice address
450 Brookline Avenue, Boston, MA 02115
Professional email
Get professional email
Personal email
Get personal email
Mobile number
Get mobile number
Social profiles

Primary practice

Dana-Farber Cancer Institute

Hospital · Boston, Massachusetts

See all 4 affiliations

Find Dr. Lynce's professional email, personal email and mobile number

Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.

View contacts for free

Dr. Filipa Lynce is a pharmacy in Boston, Massachusetts

Dr. Lynce practices at Dana-Farber Cancer Institute in Boston, Massachusetts, part of Dana-Farber Cancer Institute.

Dr. Lynce's NPI, 1144451261, was assigned on August 6, 2009.

NPI and contact details
Medicare PAC ID
5294052742
NPI enumeration date
August 6, 2009
NPI status
Active
Accepts Medicare assignment
Yes
Offers telehealth
Yes
Professional email
Get email
Personal email
Get email
Mobile number
Get number
Sex
Female
Estimated age
48
Medical school graduation
2004

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)

Dr. Filipa Lynce practices at Dana-Farber Cancer Institute in Boston, Massachusetts

Dr. Lynce's primary practice is Dana-Farber Cancer Institute, at 450 Brookline Avenue, Boston, MA 02115.

Source: Dmand AI Affiliation Data

Dr. Filipa Lynce is affiliated with 3 sites of care and 1 medical group

Dr. Lynce's primary practice is Dana-Farber Cancer Institute in Boston, Massachusetts, part of Dana-Farber Cancer Institute. Dr. Lynce is also affiliated with Brigham and Women's Hospital. The medical group on file is Binney Medical Group. Dmand AI also links Dr. Lynce to 1 more hospital, named with a free account.

See all 4 affiliations for Dr. Lynce

Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data

Dmand AI tracks the EHR system at Dr. Filipa Lynce's practice

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Lynce practices, 3 sites in all. Vendor and product names are available with a free account.

EHR by site
SiteEHR vendor and product
Dana-Farber Cancer InstituteAvailable with a free account
+2 more affiliated sitesAvailable with a free account

Source: Dmand AI Technology Install Data

For health IT teams

See the EHR and IT leaders at every hospital where Dr. Lynce practices

Dmand AI maps EHR vendors, IT decision makers and buying committees across Dana-Farber Cancer Institute and 6.2K+ hospitals, with verified contacts in the same login.

Dr. Filipa Lynce's specialty is pharmacy

Pharmacy is Dr. Lynce's primary specialty in the NPI Registry, under taxonomy code 333600000X. Dr. Lynce has a license on file in District of Columbia.

Specialties and state licenses

  • Medical oncology, District of ColumbiaLicense MD039890 · taxonomy 207RX0202X

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks

Dr. Filipa Lynce treated 76 Medicare patients in 2024, average age 71

CMS counts 76 Medicare patients who saw Dr. Lynce in 2024. The largest group is 65 to 74, with 40 patients. 75% of them have cancer, and 75% have high cholesterol. 18% are also on Medicaid. Their average risk score is 1.97, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Lynce's median patient age at 63, with 98% women.

Medicare patients, 202476
Average age71
Average risk score1.97
Also on Medicaid18%

Dr. Lynce's Medicare patients by age, 2024

CMS leaves out age groups with fewer than 11 patients.

Chronic conditions among Dr. Lynce's Medicare patients, 2024

  1. Cancer75%
  2. High cholesterol75%
  3. High blood pressure70%
  4. Arthritis47%
  5. Anxiety41%
  6. Mood disorders39%
  7. Depression36%
  8. Osteoporosis28%

Share of Medicare patients with each condition. A patient can have several.

Dr. Lynce's patients across all payers

Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.

Patient panel by age, all payers

Median age 63

Patient panel by sex, all payers

  • Women98%
  • Men1%

Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data

Dr. Filipa Lynce wrote 39 Medicare Part D claims in 2024

In 2024, Dr. Lynce wrote 39 Medicare Part D claims for 18 patients. 95% of them were for generic drugs.

Part D claims, 202439
Part D patients18

Dr. Lynce's Part D claims by kind of drug, 2024

  • Generic37 claims95%
  • Brand-name and other2 claims5%

Source: Medicare Part D Prescribers - by Provider (CMS), 2024 data

Dr. Filipa Lynce scored 84 out of 100 in Medicare's MIPS program for 2024

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Lynce for performance year 2024, reported as part of a group. Dr. Lynce accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Lynce as offering telehealth.

Accepts Medicare assignment
Yes
Offers telehealth
Yes

Dr. Lynce's MIPS scores, performance year 2024

  • 84of 100Final score
  • 65of 100Quality
  • 100of 100Promoting Interoperability
  • 40of 100Improvement Activities
  • 69of 100Cost

Each score is out of 100. The final score weighs the categories CMS scored for this clinician.

Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026

For MedTech and pharma teams

Find pharmacys like Dr. Lynce by procedure volume and prescribing

Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.

Dr. Filipa Lynce received $11,482 in industry payments in 2025

CMS Open Payments shows 10 general payments to Dr. Lynce from 2 drug and device companies in 2025. Consulting fees make up the largest share, 97% of the total. AstraZeneca Pharmaceuticals LP paid the most, $11,368. It also lists 3 research payments totaling $4,310 in 2025.

General payments to Dr. Lynce by kind, 2025 to 2025

$11.5Kin total
  • Consulting fees$11,18497%
  • Food and beverage$2983%

Companies that paid Dr. Lynce the most, 2025 to 2025

Share is of all general payments to this clinician.

See all payments to Dr. Lynce

Source: Open Payments (CMS), 2025 data, released July 7, 2026

Sources for Dr. Filipa Lynce's profile data

Sources for the data on this page
Data on this pageSource
NPI, name, sex, specialty and licensesNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data
Practice locations and phoneDmand AI Affiliation Data
Primary practice, affiliations and health systemDmand AI Affiliation DataDmand AI Org Hierarchy Data
Medicare patients and the all-payer patient panelDmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab)
Part D prescribingMedicare Part D Prescribers - by Provider (CMS) (opens in a new tab)
MIPS scores, telehealth, assignment and procedure percentilesDoctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab)
Industry paymentsOpen Payments (CMS) (opens in a new tab)
EHR at each practice siteDmand AI Technology Install Data

Data last refreshed October 2026Report an inaccuracyRemove my information

FAQ

Frequently asked questions about Dr. Filipa Lynce

Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.

What is Dr. Filipa Lynce's NPI number?

Dr. Filipa Lynce's NPI number is 1144451261. It was assigned on August 6, 2009, and it is active in the NPI Registry.

What kind of doctor is Dr. Filipa Lynce?

Dr. Filipa Lynce is a pharmacy in Boston, Massachusetts. The primary specialty in the NPI Registry is Pharmacy (taxonomy code 333600000X).

Where does Dr. Filipa Lynce practice?

Dr. Lynce practices at 450 Brookline Avenue, Boston, MA 02115. Dr. Lynce's primary practice is Dana-Farber Cancer Institute in Boston, Massachusetts, part of Dana-Farber Cancer Institute. Dmand AI also links Dr. Lynce to 1 hospital.

Which hospitals is Dr. Filipa Lynce affiliated with?

Dr. Lynce practices at Dana-Farber Cancer Institute in Boston, Massachusetts. Dr. Lynce is also affiliated with Brigham and Women's Hospital. Dmand AI links Dr. Lynce to 1 more hospital.

What medical group is Dr. Filipa Lynce part of?

Dr. Lynce is linked to Binney Medical Group.

Does Dr. Filipa Lynce accept Medicare?

Yes. CMS lists Dr. Lynce as accepting Medicare assignment.

Does Dr. Filipa Lynce offer telehealth?

Yes. The CMS Doctors and Clinicians file lists Dr. Lynce as offering telehealth services.

What is Dr. Filipa Lynce's MIPS score?

Dr. Lynce's MIPS final score for performance year 2024 is 84 out of 100, reported as part of a group.

How many Medicare patients does Dr. Filipa Lynce see?

CMS counts 76 Medicare patients who saw Dr. Lynce in 2024, with an average age of 71.

Has Dr. Filipa Lynce received payments from drug or device companies?

CMS Open Payments shows $11,482 in general payments to Dr. Lynce from 2 companies from 2025 to 2025. The largest total came from AstraZeneca Pharmaceuticals LP.

How long has Dr. Filipa Lynce been practicing?

Dr. Lynce graduated from medical school in 2004, 22 years ago.

Selling to pharmacy practices?

See pharmacys in Massachusetts by site of care and group

Find the practices, groups and hospitals they work with, and the right people to contact at each.

  • 30 days free
  • Self-serve
  • No credit card

Cookie settings

Turn each category on or off. Your choice is kept for 12 months and you can change it here at any time.

Necessary

Always on. Sign-in, security, downloads you asked for, your cookie choice, and the page that led to a signup.

View cookies (6)
  • dm_consentDmand AI. Your cookie choices and whether your browser sent a Global Privacy Control signal. 12 months.
  • dm_ft, dm_ltDmand AI. The first and the latest page you arrived on, with the date, so a signup is credited to the page that worked. 90 days, 30 days.
  • dm_fs, dm_lsDmand AI. The first and the latest source of a visit (a search engine, a campaign or the site that linked here). 90 days, 30 days.
  • dm_dl, dm_dl_okDmand AI. After you give an email address for a download, lets you download files without being asked again. 30 days.
  • Session and CSRF cookiesDmand AI (app.dmand.ai). Sign-in and form protection in the application. Session.
  • __cf_bm, cf_clearanceCloudflare. Tells people from automated traffic and keeps the site available. 30 minutes; cf_clearance while a security check is valid.

Analytics

On unless you turn it off. How pages are used, in aggregate, and recordings of how pages are used.

View cookies (6)
  • Google Tag ManagerGoogle. Loads the analytics and marketing tags that are on. Sets no cookie of its own and does not load when both categories are off. n/a.
  • _ga, _ga_<container-id>Google Analytics 4. Visits and page views in aggregate on dmand.ai. 2 years.
  • _clck, _clskMicrosoft Clarity. Recordings and heatmaps of how pages are used, with form fields masked. 1 year, 1 day.
  • CLID, MUID, ANONCHK, MR, SMMicrosoft (clarity.ms). Set by Microsoft when Clarity loads, to recognize a browser across sites that use Clarity. Up to 1 year.
  • None (cookieless)Ahrefs Analytics. Page views in aggregate. n/a.
  • ph_<project>_posthogPostHog. Product usage, errors and performance in app.dmand.ai, used to fix bugs and improve features. 365 days.

Marketing

On unless you turn it off, and always off when your browser sends a Global Privacy Control signal. A visitor identification service tells our sales team which companies and people visit.

View cookies (6)
  • _reb2buid, _reb2butkRB2B. Recognizes a returning browser for visitor identification. 360 days, 1 year.
  • _reb2bgeoRB2B. The location used to decide whether a visit can be identified. 20 days.
  • _reb2brefRB2B. The page or site that referred the visit. 15 days.
  • _reb2bfxf, _reb2btd, _reb2bliRB2B. Links the visit to an identified business profile. 1 month.
  • _reb2bresolveRB2B. Holds a match while it is being resolved. 2 days.
  • _reb2sessionID, _reb2bloadedRB2B. The current visit, and a guard against loading the script twice. 30 minutes, 1 second.

Functional

On unless you turn it off. Remembers choices such as a collapsed section.

View cookies (none today)